Zydus Lifesciences informs about press release

19 Jul 2024 Evaluate
Zydus Lifesciences has informed that it enclosed press release ‘Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR (sitagliptin and metformin hydrochloride) extended-release tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

917.45 -4.55 (-0.49%)
12-Mar-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.00
Dr. Reddys Lab 1320.00
Cipla 1325.25
Zydus Lifesciences 917.45
Lupin 2355.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×